Search results for

A new book explores California's giant redwoods — some of the largest living organisms in the world. Devoted naturalists are climbing to the treetops to learn more about the "green ocean" overhead in the redwood canopies.

After decades of success, director Martin Scorsese has his first Oscar. His film The Departed also won Best Picture. Among actors, Forest Whitaker was honored for playing Idi Amin in The Last King of Scotland, Helen Mirren for The Queen.

NPR's Stephen Thompson reports on two new bands that are topping the Billboard charts despite being fictional K-pop groups from a new Netflix movie.

NPR Film Critic Bob Mondello presents his annual list of top ten films of the year. He says he really could only justify putting nine on the list this year.

Tom Terrell has a review of Soul on Top, a re-release of a James Brown recording from 1970. On it, Brown sings jazz tunes such as "September Song" and "What kind of Fool am I?"

Sprint Corporation confirms its two top executives are leaving the company. The Wall Street Journal reports that CEO William Esrey and President Ronald LeMay were forced out in a boardroom dispute over their use of a tax shelter. Matt Hackworth of member station KCUR reports.

Alistair Campbell, British Prime Minister Tony Blair's top media strategist, steps down amid accusations that he helped exaggerate evidence on Iraq's weapons programs. The British media had dubbed Campbell the "real deputy prime minister." Campbell cites family reasons for his resignation. Hear NPR's Guy Raz.

New York Times environmental reporter Andrew Revkin has covered climate change and climate politics for 20 years. His new book The North Pole Was Here: Puzzles and Perils at the Top of the World is geared toward young adults.

Rock critic Ken Tucker offers up his top 10 lists of the best albums and singles of 2008.music. Here's his look at some of his own favorites.

Rumors have been circulating for some time that -- just like in the world of sports -- classical musicians are using performance-enhancing drugs. NPR's Tom Goldman talks to NPR's Lisa Simeone about the speculations.